Reed asserts that individuals at the Center are using experimental drugs on children, distributing puberty blockers and cross-sex hormones without individualized assessment, and even without parental consent
In 2019, Reed started noticing a growing number of patients deciding not to go through with “transition,” or deciding to embrace their biological gender. She and her colleague started collating information about those patients with the assumption that the doctors would want to know about their change of heart. But the doctors did not.
She noted that the girls who came to the Center had many comorbidities such as depression, anxiety, ADHD, eating disorders, and obesity. Many were diagnosed with autism or had autism-like symptoms. Frequently, patients declared they had disorders that no one believed they had. The doctors privately recognized these false self-diagnoses as a manifestation of social contagion. They even acknowledged that suicide has an element of social contagion. But when clusters of girls streaming into the Center looked as if their gender issues might be a manifestation of social contagion, the doctors said gender identity reflected something innate.
Reed also acknowledged that all that was required for a child to “transition” was a letter of support from a therapist, typically one recommended by the staff, and who the patient had to see only once or twice for the green light. To make it more efficient for the therapists, the Center offered them a template for how to write a letter in support of “transition.” The next stop was then a single visit to the endocrinologist for a testosterone prescription.
In her sworn affidavit for the Missouri Attorney General’s office, Reed asserts that individuals at the Center are using experimental drugs on children, distributing puberty blockers and cross-sex hormones without individualized assessment, and even without parental consent. Bicalutamide is a medication used to treat metastatic prostate cancer, and one of its side effects is that it feminizes the bodies of men who take it, including the appearance of breasts. The Center prescribed this cancer drug as a puberty blocker and feminizing agent for boys. As with most cancer drugs, bicalutamide has a long list of side effects including liver toxicity. There also are no clinical studies for using this drug for gender confusion, and there are no established standards of care for using this drug.
In addition, these “transitioning” methods have led children to attempt suicide and the Center never discontinues prescribing cross-sex hormones, no matter how much those drugs are harming the child. Reed also has provided evidence that the Center has been unlawfully billing state taxpayers to fund these actions.